|
|
|
|
|
|
|
|
|
|
|
|
|
08.12.25 - 14:36
|
Nike Beats Estimates by 81% While Under Armour Swings to Loss (24/7 Wall St.)
|
|
|
Nike (NYSE: NKE) and Under Armour (NYSE: UA) reported recent earnings revealing two athletic brands moving in opposite directions. Nike beat estimates by 81% in Q1 FY2026 while fighting margin pressure. Under Armour missed by 116% in Q2 FY2026, swinging from profit to loss year over year. One Beat Big. One Collapsed. Nike reported $0.49 ... Nike Beats Estimates by 81% While Under Armour Swings to Loss
The post Nike Beats Estimates by 81% While Under Armour Swings to Loss appeared first on 24/7 Wall St.....
|
|
|
08.12.25 - 14:36
|
Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump (24/7 Wall St.)
|
|
|
Abbott Laboratories (NYSE: ABT) and Eli Lilly (NYSE: LLY) just reported Q3 earnings that highlight two fundamentally different healthcare bets. Abbott delivered steady 6.9% revenue growth anchored by medical devices. Lilly posted explosive 54% revenue growth powered by its GLP-1 obesity and diabetes drugs. Medical Devices Carry Abbott. GLP-1s Carry Lilly. Abbott's medical device segment ... Lilly's GLP-1 Surge Dwarfs Abbott's Steady Device Growth With 54% Revenue Jump
The post Lilly's GLP-1 Surge Dwarfs Abbott's Steady Device Growth With 54% Revenue Jump appeared first on 24/7 Wall St.....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|